Advertisement

Index by author

January 01, 2011; Volume 79,Issue 1

A

  1. Abada, Paolo B.

    1. Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Catherine E. Pesce, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology January 2011, 79 (1) 157-166; DOI: https://doi.org/10.1124/mol.110.068411

  2. Abbruzzese, Jennifer

    1. Molecular Determinants of Human ether-à-go-go-Related Gene 1 (hERG1) K+ Channel Activation by NS1643
      Morten Grunnet, Jennifer Abbruzzese, Frank B. Sachse and Michael C. Sanguinetti
      Molecular Pharmacology January 2011, 79 (1) 1-9; DOI: https://doi.org/10.1124/mol.110.067728

  3. Abraham, William M.

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  4. Adams, Preston L.

    1. Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Catherine E. Pesce, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology January 2011, 79 (1) 157-166; DOI: https://doi.org/10.1124/mol.110.068411

  5. Ammosova, Tatyana

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

B

  1. Berrettini, Wade

    1. Acetylcholine Receptor (AChR) α5 Subunit Variant Associated with Risk for Nicotine Dependence and Lung Cancer Reduces (α4β2)2α5 AChR Function
      Alexander Kuryatov, Wade Berrettini and Jon Lindstrom
      Molecular Pharmacology January 2011, 79 (1) 119-125; DOI: https://doi.org/10.1124/mol.110.066357

  2. Bhave, Gautam

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  3. Blair, Brian G.

    1. Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Catherine E. Pesce, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology January 2011, 79 (1) 157-166; DOI: https://doi.org/10.1124/mol.110.068411

  4. Breuer, Denitra

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  5. Brueggemann, Lioubov I.

    1. Diclofenac Distinguishes among Homomeric and Heteromeric Potassium Channels Composed of KCNQ4 and KCNQ5 Subunits
      Lioubov I. Brueggemann, Alexander R. Mackie, Jody L. Martin, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology January 2011, 79 (1) 10-23; DOI: https://doi.org/10.1124/mol.110.067496

  6. Byrd, John C.

    1. Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
      Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, Aaron M. Sargeant, Samuel K. Kulp, Che-Ming Teng, John C. Byrd and Ching-Shih Chen
      Molecular Pharmacology January 2011, 79 (1) 197-206; DOI: https://doi.org/10.1124/mol.110.067702

  7. Byron, Kenneth L.

    1. Diclofenac Distinguishes among Homomeric and Heteromeric Potassium Channels Composed of KCNQ4 and KCNQ5 Subunits
      Lioubov I. Brueggemann, Alexander R. Mackie, Jody L. Martin, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology January 2011, 79 (1) 10-23; DOI: https://doi.org/10.1124/mol.110.067496

C

  1. Chauder, Brian A.

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  2. Chen, Ching-Shih

    1. Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
      Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, Aaron M. Sargeant, Samuel K. Kulp, Che-Ming Teng, John C. Byrd and Ching-Shih Chen
      Molecular Pharmacology January 2011, 79 (1) 197-206; DOI: https://doi.org/10.1124/mol.110.067702

  3. Chen, Chun-Han

    1. Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
      Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, Aaron M. Sargeant, Samuel K. Kulp, Che-Ming Teng, John C. Byrd and Ching-Shih Chen
      Molecular Pharmacology January 2011, 79 (1) 197-206; DOI: https://doi.org/10.1124/mol.110.067702

  4. Chen, Gang

    1. Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
      Zhi-Jun Sun, Gang Chen, Wei Zhang, Xiang Hu, Yang Liu, Qian Zhou, Ling-Xing Zhu and Yi-Fang Zhao
      Molecular Pharmacology January 2011, 79 (1) 106-118; DOI: https://doi.org/10.1124/mol.110.066910

  5. Chou, Chih-Chien

    1. Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
      Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, Aaron M. Sargeant, Samuel K. Kulp, Che-Ming Teng, John C. Byrd and Ching-Shih Chen
      Molecular Pharmacology January 2011, 79 (1) 197-206; DOI: https://doi.org/10.1124/mol.110.067702

  6. Copello, Julio A.

    1. CGP-37157 Inhibits the Sarcoplasmic Reticulum Ca2+ ATPase and Activates Ryanodine Receptor Channels in Striated Muscle
      Jake T. Neumann, Paula L. Diaz-Sylvester, Sidney Fleischer and Julio A. Copello
      Molecular Pharmacology January 2011, 79 (1) 141-147; DOI: https://doi.org/10.1124/mol.110.067165

  7. Crackower, Michael A.

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  8. Cribbs, Leanne L.

    1. Diclofenac Distinguishes among Homomeric and Heteromeric Potassium Channels Composed of KCNQ4 and KCNQ5 Subunits
      Lioubov I. Brueggemann, Alexander R. Mackie, Jody L. Martin, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology January 2011, 79 (1) 10-23; DOI: https://doi.org/10.1124/mol.110.067496

D

  1. Dale, Lianne B.

    1. Rab GTPases Bind at a Common Site within the Angiotensin II Type I Receptor Carboxyl-Terminal Tail: Evidence that Rab4 Regulates Receptor Phosphorylation, Desensitization, and Resensitization
      Jessica L. Esseltine, Lianne B. Dale and Stephen S. G. Ferguson
      Molecular Pharmacology January 2011, 79 (1) 175-184; DOI: https://doi.org/10.1124/mol.110.068379

  2. Dawson, Eric S.

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  3. Debebe, Zufan

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  4. Denis, Danielle

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  5. Denton, Jerod S.

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  6. Dessal, Axel L.

    1. Rational Design of a Selective Covalent Modifier of G Protein βγ Subunits
      Axel L. Dessal, Roger Prades, Ernest Giralt and Alan V. Smrcka
      Molecular Pharmacology January 2011, 79 (1) 24-33; DOI: https://doi.org/10.1124/mol.110.068155

  7. Diaz-Sylvester, Paula L.

    1. CGP-37157 Inhibits the Sarcoplasmic Reticulum Ca2+ ATPase and Activates Ryanodine Receptor Channels in Striated Muscle
      Jake T. Neumann, Paula L. Diaz-Sylvester, Sidney Fleischer and Julio A. Copello
      Molecular Pharmacology January 2011, 79 (1) 141-147; DOI: https://doi.org/10.1124/mol.110.067165

E

  1. Esseltine, Jessica L.

    1. Rab GTPases Bind at a Common Site within the Angiotensin II Type I Receptor Carboxyl-Terminal Tail: Evidence that Rab4 Regulates Receptor Phosphorylation, Desensitization, and Resensitization
      Jessica L. Esseltine, Lianne B. Dale and Stephen S. G. Ferguson
      Molecular Pharmacology January 2011, 79 (1) 175-184; DOI: https://doi.org/10.1124/mol.110.068379

F

  1. Ferguson, Stephen S. G.

    1. Rab GTPases Bind at a Common Site within the Angiotensin II Type I Receptor Carboxyl-Terminal Tail: Evidence that Rab4 Regulates Receptor Phosphorylation, Desensitization, and Resensitization
      Jessica L. Esseltine, Lianne B. Dale and Stephen S. G. Ferguson
      Molecular Pharmacology January 2011, 79 (1) 175-184; DOI: https://doi.org/10.1124/mol.110.068379

  2. Fleischer, Sidney

    1. CGP-37157 Inhibits the Sarcoplasmic Reticulum Ca2+ ATPase and Activates Ryanodine Receptor Channels in Striated Muscle
      Jake T. Neumann, Paula L. Diaz-Sylvester, Sidney Fleischer and Julio A. Copello
      Molecular Pharmacology January 2011, 79 (1) 141-147; DOI: https://doi.org/10.1124/mol.110.067165

G

  1. Gallant, Michel

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  2. Gervais, Francois G.

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  3. Giralt, Ernest

    1. Rational Design of a Selective Covalent Modifier of G Protein βγ Subunits
      Axel L. Dessal, Roger Prades, Ernest Giralt and Alan V. Smrcka
      Molecular Pharmacology January 2011, 79 (1) 24-33; DOI: https://doi.org/10.1124/mol.110.068155

  4. Gordeuk, Victor R.

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  5. Grunnet, Morten

    1. Molecular Determinants of Human ether-à-go-go-Related Gene 1 (hERG1) K+ Channel Activation by NS1643
      Morten Grunnet, Jennifer Abbruzzese, Frank B. Sachse and Michael C. Sanguinetti
      Molecular Pharmacology January 2011, 79 (1) 1-9; DOI: https://doi.org/10.1124/mol.110.067728

H

  1. Halaszovich, Christian R.

    1. Aminoglycosides Inhibit KCNQ4 Channels in Cochlear Outer Hair Cells via Depletion of Phosphatidylinositol(4,5)bisphosphate
      Michael G. Leitner, Christian R. Halaszovich and Dominik Oliver
      Molecular Pharmacology January 2011, 79 (1) 51-60; DOI: https://doi.org/10.1124/mol.110.068130

  2. Hamel, Martine

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  3. Hosur, Vishnu

    1. α4β2 Nicotinic Receptors Partially Mediate Anti-Inflammatory Effects through Janus Kinase 2-Signal Transducer and Activator of Transcription 3 but Not Calcium or cAMP Signaling
      Vishnu Hosur and Ralph H. Loring
      Molecular Pharmacology January 2011, 79 (1) 167-174; DOI: https://doi.org/10.1124/mol.110.066381

  4. Howell, Stephen B.

    1. Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Catherine E. Pesce, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology January 2011, 79 (1) 157-166; DOI: https://doi.org/10.1124/mol.110.068411

  5. Hu, Xiang

    1. Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
      Zhi-Jun Sun, Gang Chen, Wei Zhang, Xiang Hu, Yang Liu, Qian Zhou, Ling-Xing Zhu and Yi-Fang Zhao
      Molecular Pharmacology January 2011, 79 (1) 106-118; DOI: https://doi.org/10.1124/mol.110.066910

  6. Huang, Po-Hsien

    1. Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
      Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, Aaron M. Sargeant, Samuel K. Kulp, Che-Ming Teng, John C. Byrd and Ching-Shih Chen
      Molecular Pharmacology January 2011, 79 (1) 197-206; DOI: https://doi.org/10.1124/mol.110.067702

I

  1. Ii, Masayuki

    1. TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
      Naoko Matsunaga, Noboru Tsuchimori, Tatsumi Matsumoto and Masayuki Ii
      Molecular Pharmacology January 2011, 79 (1) 34-41; DOI: https://doi.org/10.1124/mol.110.068064

  2. Inoue, Shin-ichi

    1. Activated Sterol Regulatory Element-Binding Protein-2 Suppresses Hepatocyte Nuclear Factor-4-Mediated Cyp3a11 Expression in Mouse Liver
      Shin-ichi Inoue, Kouichi Yoshinari, Mika Sugawara and Yasushi Yamazoe
      Molecular Pharmacology January 2011, 79 (1) 148-156; DOI: https://doi.org/10.1124/mol.110.068577

J

  1. Jerebtsova, Marina

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  2. Jutila, Mark A.

    1. Gastrin-Releasing Peptide/Neuromedin B Receptor Antagonists PD176252, PD168368, and Related Analogs Are Potent Agonists of Human Formyl-Peptide Receptors
      Igor A. Schepetkin, Liliya N. Kirpotina, Andrei I. Khlebnikov, Mark A. Jutila and Mark T. Quinn
      Molecular Pharmacology January 2011, 79 (1) 77-90; DOI: https://doi.org/10.1124/mol.110.068288

K

  1. Kadakia, Rishin

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  2. Kago, Tomoyuki

    1. Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs
      David Marsolais, Saiko Yagi, Tomoyuki Kago, Nora Leaf and Hugh Rosen
      Molecular Pharmacology January 2011, 79 (1) 61-68; DOI: https://doi.org/10.1124/mol.110.066811

  3. Kalinowski, Danuta S.

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  4. Karla, Pradeep K.

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  5. Kashanchi, Fatah

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  6. Khlebnikov, Andrei I.

    1. Gastrin-Releasing Peptide/Neuromedin B Receptor Antagonists PD176252, PD168368, and Related Analogs Are Potent Agonists of Human Formyl-Peptide Receptors
      Igor A. Schepetkin, Liliya N. Kirpotina, Andrei I. Khlebnikov, Mark A. Jutila and Mark T. Quinn
      Molecular Pharmacology January 2011, 79 (1) 77-90; DOI: https://doi.org/10.1124/mol.110.068288

  7. Kirpotina, Liliya N.

    1. Gastrin-Releasing Peptide/Neuromedin B Receptor Antagonists PD176252, PD168368, and Related Analogs Are Potent Agonists of Human Formyl-Peptide Receptors
      Igor A. Schepetkin, Liliya N. Kirpotina, Andrei I. Khlebnikov, Mark A. Jutila and Mark T. Quinn
      Molecular Pharmacology January 2011, 79 (1) 77-90; DOI: https://doi.org/10.1124/mol.110.068288

  8. Krawczyk, Connie

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  9. Kulp, Samuel K.

    1. Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
      Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, Aaron M. Sargeant, Samuel K. Kulp, Che-Ming Teng, John C. Byrd and Ching-Shih Chen
      Molecular Pharmacology January 2011, 79 (1) 197-206; DOI: https://doi.org/10.1124/mol.110.067702

  10. Kumar, Krishna

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  11. Kuryatov, Alexander

    1. Acetylcholine Receptor (AChR) α5 Subunit Variant Associated with Risk for Nicotine Dependence and Lung Cancer Reduces (α4β2)2α5 AChR Function
      Alexander Kuryatov, Wade Berrettini and Jon Lindstrom
      Molecular Pharmacology January 2011, 79 (1) 119-125; DOI: https://doi.org/10.1124/mol.110.066357

  12. Kuryatov, Alexandre

    1. Expression of Functional Human α6β2β3* Acetylcholine Receptors in Xenopus laevis Oocytes Achieved through Subunit Chimeras and Concatamers
      Alexandre Kuryatov and Jon Lindstrom
      Molecular Pharmacology January 2011, 79 (1) 126-140; DOI: https://doi.org/10.1124/mol.110.066159

L

  1. Larson, Christopher A.

    1. Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Catherine E. Pesce, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology January 2011, 79 (1) 157-166; DOI: https://doi.org/10.1124/mol.110.068411

  2. Leaf, Nora

    1. Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs
      David Marsolais, Saiko Yagi, Tomoyuki Kago, Nora Leaf and Hugh Rosen
      Molecular Pharmacology January 2011, 79 (1) 61-68; DOI: https://doi.org/10.1124/mol.110.066811

  3. Leitner, Michael G.

    1. Aminoglycosides Inhibit KCNQ4 Channels in Cochlear Outer Hair Cells via Depletion of Phosphatidylinositol(4,5)bisphosphate
      Michael G. Leitner, Christian R. Halaszovich and Dominik Oliver
      Molecular Pharmacology January 2011, 79 (1) 51-60; DOI: https://doi.org/10.1124/mol.110.068130

  4. Lewis, L. Michelle

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  5. Lindsley, Craig W.

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  6. Lindstrom, Jon

    1. Expression of Functional Human α6β2β3* Acetylcholine Receptors in Xenopus laevis Oocytes Achieved through Subunit Chimeras and Concatamers
      Alexandre Kuryatov and Jon Lindstrom
      Molecular Pharmacology January 2011, 79 (1) 126-140; DOI: https://doi.org/10.1124/mol.110.066159
    2. Acetylcholine Receptor (AChR) α5 Subunit Variant Associated with Risk for Nicotine Dependence and Lung Cancer Reduces (α4β2)2α5 AChR Function
      Alexander Kuryatov, Wade Berrettini and Jon Lindstrom
      Molecular Pharmacology January 2011, 79 (1) 119-125; DOI: https://doi.org/10.1124/mol.110.066357

  7. Liu, Wen

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  8. Liu, Yang

    1. Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
      Zhi-Jun Sun, Gang Chen, Wei Zhang, Xiang Hu, Yang Liu, Qian Zhou, Ling-Xing Zhu and Yi-Fang Zhao
      Molecular Pharmacology January 2011, 79 (1) 106-118; DOI: https://doi.org/10.1124/mol.110.066910

  9. Loring, Ralph H.

    1. α4β2 Nicotinic Receptors Partially Mediate Anti-Inflammatory Effects through Janus Kinase 2-Signal Transducer and Activator of Transcription 3 but Not Calcium or cAMP Signaling
      Vishnu Hosur and Ralph H. Loring
      Molecular Pharmacology January 2011, 79 (1) 167-174; DOI: https://doi.org/10.1124/mol.110.066381

  10. Lovejoy, David B.

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

M

  1. Mackie, Alexander R.

    1. Diclofenac Distinguishes among Homomeric and Heteromeric Potassium Channels Composed of KCNQ4 and KCNQ5 Subunits
      Lioubov I. Brueggemann, Alexander R. Mackie, Jody L. Martin, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology January 2011, 79 (1) 10-23; DOI: https://doi.org/10.1124/mol.110.067496

  2. Mannoury la Cour, Clotilde

    1. Signaling Pathways Leading to Phosphorylation of Akt and GSK-3β by Activation of Cloned Human and Rat Cerebral D2 and D3 Receptors
      Clotilde Mannoury la Cour, Marie-Josèphe Salles, Valérie Pasteau and Mark J. Millan
      Molecular Pharmacology January 2011, 79 (1) 91-105; DOI: https://doi.org/10.1124/mol.110.065409

  3. Marsolais, David

    1. Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs
      David Marsolais, Saiko Yagi, Tomoyuki Kago, Nora Leaf and Hugh Rosen
      Molecular Pharmacology January 2011, 79 (1) 61-68; DOI: https://doi.org/10.1124/mol.110.066811

  4. Martin, Jody L.

    1. Diclofenac Distinguishes among Homomeric and Heteromeric Potassium Channels Composed of KCNQ4 and KCNQ5 Subunits
      Lioubov I. Brueggemann, Alexander R. Mackie, Jody L. Martin, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology January 2011, 79 (1) 10-23; DOI: https://doi.org/10.1124/mol.110.067496

  5. Matsumoto, Tatsumi

    1. TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
      Naoko Matsunaga, Noboru Tsuchimori, Tatsumi Matsumoto and Masayuki Ii
      Molecular Pharmacology January 2011, 79 (1) 34-41; DOI: https://doi.org/10.1124/mol.110.068064

  6. Matsunaga, Naoko

    1. TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
      Naoko Matsunaga, Noboru Tsuchimori, Tatsumi Matsumoto and Masayuki Ii
      Molecular Pharmacology January 2011, 79 (1) 34-41; DOI: https://doi.org/10.1124/mol.110.068064

  7. Meiler, Jens

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  8. Millan, Mark J.

    1. Signaling Pathways Leading to Phosphorylation of Akt and GSK-3β by Activation of Cloned Human and Rat Cerebral D2 and D3 Receptors
      Clotilde Mannoury la Cour, Marie-Josèphe Salles, Valérie Pasteau and Mark J. Millan
      Molecular Pharmacology January 2011, 79 (1) 91-105; DOI: https://doi.org/10.1124/mol.110.065409

N

  1. Nekhai, Sergei

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  2. Neumann, Jake T.

    1. CGP-37157 Inhibits the Sarcoplasmic Reticulum Ca2+ ATPase and Activates Ryanodine Receptor Channels in Striated Muscle
      Jake T. Neumann, Paula L. Diaz-Sylvester, Sidney Fleischer and Julio A. Copello
      Molecular Pharmacology January 2011, 79 (1) 141-147; DOI: https://doi.org/10.1124/mol.110.067165

  3. Nguyen, Thuy T.

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

O

  1. O'Neill, Gary P.

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  2. Oliver, Dominik

    1. Aminoglycosides Inhibit KCNQ4 Channels in Cochlear Outer Hair Cells via Depletion of Phosphatidylinositol(4,5)bisphosphate
      Michael G. Leitner, Christian R. Halaszovich and Dominik Oliver
      Molecular Pharmacology January 2011, 79 (1) 51-60; DOI: https://doi.org/10.1124/mol.110.068130

P

  1. Pasteau, Valérie

    1. Signaling Pathways Leading to Phosphorylation of Akt and GSK-3β by Activation of Cloned Human and Rat Cerebral D2 and D3 Receptors
      Clotilde Mannoury la Cour, Marie-Josèphe Salles, Valérie Pasteau and Mark J. Millan
      Molecular Pharmacology January 2011, 79 (1) 91-105; DOI: https://doi.org/10.1124/mol.110.065409

  2. Pesce, Catherine E.

    1. Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Catherine E. Pesce, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology January 2011, 79 (1) 157-166; DOI: https://doi.org/10.1124/mol.110.068411

  3. Prades, Roger

    1. Rational Design of a Selective Covalent Modifier of G Protein βγ Subunits
      Axel L. Dessal, Roger Prades, Ernest Giralt and Alan V. Smrcka
      Molecular Pharmacology January 2011, 79 (1) 24-33; DOI: https://doi.org/10.1124/mol.110.068155

Q

  1. Quinn, Mark T.

    1. Gastrin-Releasing Peptide/Neuromedin B Receptor Antagonists PD176252, PD168368, and Related Analogs Are Potent Agonists of Human Formyl-Peptide Receptors
      Igor A. Schepetkin, Liliya N. Kirpotina, Andrei I. Khlebnikov, Mark A. Jutila and Mark T. Quinn
      Molecular Pharmacology January 2011, 79 (1) 77-90; DOI: https://doi.org/10.1124/mol.110.068288

R

  1. Ray, Patricio

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  2. Richardson, Des R.

    1. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
      Zufan Debebe, Tatyana Ammosova, Denitra Breuer, David B. Lovejoy, Danuta S. Kalinowski, Pradeep K. Karla, Krishna Kumar, Marina Jerebtsova, Patricio Ray, Fatah Kashanchi, Victor R. Gordeuk, Des R. Richardson and Sergei Nekhai
      Molecular Pharmacology January 2011, 79 (1) 185-196; DOI: https://doi.org/10.1124/mol.110.069062

  3. Rosen, Hugh

    1. Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs
      David Marsolais, Saiko Yagi, Tomoyuki Kago, Nora Leaf and Hugh Rosen
      Molecular Pharmacology January 2011, 79 (1) 61-68; DOI: https://doi.org/10.1124/mol.110.066811

S

  1. Sachse, Frank B.

    1. Molecular Determinants of Human ether-à-go-go-Related Gene 1 (hERG1) K+ Channel Activation by NS1643
      Morten Grunnet, Jennifer Abbruzzese, Frank B. Sachse and Michael C. Sanguinetti
      Molecular Pharmacology January 2011, 79 (1) 1-9; DOI: https://doi.org/10.1124/mol.110.067728

  2. Safaei, Roohangiz

    1. Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Catherine E. Pesce, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology January 2011, 79 (1) 157-166; DOI: https://doi.org/10.1124/mol.110.068411

  3. Salles, Marie-Josèphe

    1. Signaling Pathways Leading to Phosphorylation of Akt and GSK-3β by Activation of Cloned Human and Rat Cerebral D2 and D3 Receptors
      Clotilde Mannoury la Cour, Marie-Josèphe Salles, Valérie Pasteau and Mark J. Millan
      Molecular Pharmacology January 2011, 79 (1) 91-105; DOI: https://doi.org/10.1124/mol.110.065409

  4. Sanguinetti, Michael C.

    1. Molecular Determinants of Human ether-à-go-go-Related Gene 1 (hERG1) K+ Channel Activation by NS1643
      Morten Grunnet, Jennifer Abbruzzese, Frank B. Sachse and Michael C. Sanguinetti
      Molecular Pharmacology January 2011, 79 (1) 1-9; DOI: https://doi.org/10.1124/mol.110.067728

  5. Sargeant, Aaron M.

    1. Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
      Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, Aaron M. Sargeant, Samuel K. Kulp, Che-Ming Teng, John C. Byrd and Ching-Shih Chen
      Molecular Pharmacology January 2011, 79 (1) 197-206; DOI: https://doi.org/10.1124/mol.110.067702

  6. Satlin, Lisa M.

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  7. Sawyer, Nicole

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  8. Schepetkin, Igor A.

    1. Gastrin-Releasing Peptide/Neuromedin B Receptor Antagonists PD176252, PD168368, and Related Analogs Are Potent Agonists of Human Formyl-Peptide Receptors
      Igor A. Schepetkin, Liliya N. Kirpotina, Andrei I. Khlebnikov, Mark A. Jutila and Mark T. Quinn
      Molecular Pharmacology January 2011, 79 (1) 77-90; DOI: https://doi.org/10.1124/mol.110.068288

  9. Sillaots, Susan

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  10. Slipetz, Deborah

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  11. Smrcka, Alan V.

    1. Rational Design of a Selective Covalent Modifier of G Protein βγ Subunits
      Axel L. Dessal, Roger Prades, Ernest Giralt and Alan V. Smrcka
      Molecular Pharmacology January 2011, 79 (1) 24-33; DOI: https://doi.org/10.1124/mol.110.068155

  12. Stocco, Rino

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  13. Sugawara, Mika

    1. Activated Sterol Regulatory Element-Binding Protein-2 Suppresses Hepatocyte Nuclear Factor-4-Mediated Cyp3a11 Expression in Mouse Liver
      Shin-ichi Inoue, Kouichi Yoshinari, Mika Sugawara and Yasushi Yamazoe
      Molecular Pharmacology January 2011, 79 (1) 148-156; DOI: https://doi.org/10.1124/mol.110.068577

  14. Sun, Zhi-Jun

    1. Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
      Zhi-Jun Sun, Gang Chen, Wei Zhang, Xiang Hu, Yang Liu, Qian Zhou, Ling-Xing Zhu and Yi-Fang Zhao
      Molecular Pharmacology January 2011, 79 (1) 106-118; DOI: https://doi.org/10.1124/mol.110.066910

T

  1. Teng, Che-Ming

    1. Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
      Po-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, Aaron M. Sargeant, Samuel K. Kulp, Che-Ming Teng, John C. Byrd and Ching-Shih Chen
      Molecular Pharmacology January 2011, 79 (1) 197-206; DOI: https://doi.org/10.1124/mol.110.067702

  2. Tsuchimori, Noboru

    1. TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
      Naoko Matsunaga, Noboru Tsuchimori, Tatsumi Matsumoto and Masayuki Ii
      Molecular Pharmacology January 2011, 79 (1) 34-41; DOI: https://doi.org/10.1124/mol.110.068064

W

  1. Wang, Zhaoyin

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

  2. Weaver, C. David

    1. Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel
      Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin Kadakia, Thuy T. Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology January 2011, 79 (1) 42-50; DOI: https://doi.org/10.1124/mol.110.066928

  3. Wong, Elizabeth

    1. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
      Francois G. Gervais, Nicole Sawyer, Rino Stocco, Martine Hamel, Connie Krawczyk, Susan Sillaots, Danielle Denis, Elizabeth Wong, Zhaoyin Wang, Michel Gallant, William M. Abraham, Deborah Slipetz, Michael A. Crackower and Gary P. O'Neill
      Molecular Pharmacology January 2011, 79 (1) 69-76; DOI: https://doi.org/10.1124/mol.110.068585

Y

  1. Yagi, Saiko

    1. Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs
      David Marsolais, Saiko Yagi, Tomoyuki Kago, Nora Leaf and Hugh Rosen
      Molecular Pharmacology January 2011, 79 (1) 61-68; DOI: https://doi.org/10.1124/mol.110.066811

  2. Yamazoe, Yasushi

    1. Activated Sterol Regulatory Element-Binding Protein-2 Suppresses Hepatocyte Nuclear Factor-4-Mediated Cyp3a11 Expression in Mouse Liver
      Shin-ichi Inoue, Kouichi Yoshinari, Mika Sugawara and Yasushi Yamazoe
      Molecular Pharmacology January 2011, 79 (1) 148-156; DOI: https://doi.org/10.1124/mol.110.068577

  3. Yoshinari, Kouichi

    1. Activated Sterol Regulatory Element-Binding Protein-2 Suppresses Hepatocyte Nuclear Factor-4-Mediated Cyp3a11 Expression in Mouse Liver
      Shin-ichi Inoue, Kouichi Yoshinari, Mika Sugawara and Yasushi Yamazoe
      Molecular Pharmacology January 2011, 79 (1) 148-156; DOI: https://doi.org/10.1124/mol.110.068577

Z

  1. Zhang, Wei

    1. Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
      Zhi-Jun Sun, Gang Chen, Wei Zhang, Xiang Hu, Yang Liu, Qian Zhou, Ling-Xing Zhu and Yi-Fang Zhao
      Molecular Pharmacology January 2011, 79 (1) 106-118; DOI: https://doi.org/10.1124/mol.110.066910

  2. Zhao, Yi-Fang

    1. Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
      Zhi-Jun Sun, Gang Chen, Wei Zhang, Xiang Hu, Yang Liu, Qian Zhou, Ling-Xing Zhu and Yi-Fang Zhao
      Molecular Pharmacology January 2011, 79 (1) 106-118; DOI: https://doi.org/10.1124/mol.110.066910

  3. Zhou, Qian

    1. Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
      Zhi-Jun Sun, Gang Chen, Wei Zhang, Xiang Hu, Yang Liu, Qian Zhou, Ling-Xing Zhu and Yi-Fang Zhao
      Molecular Pharmacology January 2011, 79 (1) 106-118; DOI: https://doi.org/10.1124/mol.110.066910

  4. Zhu, Ling-Xing

    1. Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
      Zhi-Jun Sun, Gang Chen, Wei Zhang, Xiang Hu, Yang Liu, Qian Zhou, Ling-Xing Zhu and Yi-Fang Zhao
      Molecular Pharmacology January 2011, 79 (1) 106-118; DOI: https://doi.org/10.1124/mol.110.066910
Back to top

In this issue

Advertisement